A new gentler chemotherapy drug in the form of nanoparticles has been designed by Northwestern Medicine® scientists to be less toxic to a young woman’s fertility but tough on cancer. This is the first cancer drug tested while in development for its effect on fertility using a novel in vitro test. Scientists, Teresa K Woodruff, PhD, and Thomas O’Halloran, PhD, co-principal investigators of the study, developed and tested the new drug. Read more about their study here.
